ArticleEJVES vascular forum2026
Fibroadipose Vascular Anomaly: A Distinct Vascular Malformation.
Article in EJVES vascular forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Fibroadipose vascular anomaly (FAVA) is a rare and complex vascular malformation. It primarily involves the venous components and is characterised by a matrix of fibrofatty tissue. This study aimed to describe the features of FAVA that differentiate it from venous malformation (VM). Method: A retrospective series of 62 patients diagnosed with FAVA from August 2019 to February 2022 at a tertiary care centre in South India was analysed. The diagnosis was confirmed by histopathology ( Results: FAVA (43.5% males) and VM (55.6% males) presented at a mean age of 26.5 ± 13.1 and 23.7 ± 10.9 years, respectively. While both presented with swelling (93.7% and 94.4%, respectively), pain was significantly more prevalent among FAVA (87.1% Conclusion: FAVA is a clinically and radiologically distinct entity. Recognition of the characteristic MRI features of FAVA, particularly intramuscular fat and fibrosis, may aid in early diagnosis and guide appropriate multidisciplinary management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.